Literature DB >> 220922

[Gonadoblastoma and overgrowing dysgerminoma in Turner mosaicism [45, XO/46, Xi (Xq)] (author's transl)].

D Mühlenstedt, H G Bohnet, I H Pawlowitzki, H P Schneider.   

Abstract

It is well established that the Y-chromosome is associated with germ cell tumor development. There is a considerable tumour risk in XY- and XY/XO-gonadal dysgenesis. In the absence of Y-chromosome germ cell tumours are extremely rare. The history of a patient with 45 XO/46 Xi (Xq)-karyotype is presented, who had a gonadoblastoma with overgrowing dysgerminoma. According to basal body temperature recordings, this patient ovulated up to the age of 22 years. After this cyclical ovarian function was exhausted; histologically no primordial follicles could be detected. Gonadotropin as well as prolactin binding sites in the tumours could not be demonstrated, suggesting hormone independency and complete malignant transformation of the tumor. In general the clinician should be aware of a possible germ cell tumour development in the absence of a Y-chromosome. However as far as the clinical management of patients with dysgenetic gonads is concerned, prophylactic gonadectomy is only indicated in the presence of a Y-chromosome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220922     DOI: 10.1007/bf02108627

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  24 in total

1.  ["Ovarian" disgerminoma with isosexual precocious puberty and subsequent virilization (gonadoblastoma according to Scully)].

Authors:  A BORGHI; R TOCCAFONDI; G GIUSTI
Journal:  Folia Endocrinol       Date:  1962-12

2.  THE XO SYNDROME. A STUDY OF THE DIFFERENTIATED PHENOTYPE IN 25 PATIENTS.

Authors:  L LEMLI; D W SMITH
Journal:  J Pediatr       Date:  1963-10       Impact factor: 4.406

Review 3.  KARYOTYPE-PHENOTYPE CORRELATIONS IN GONADAL DYSGENESIS AND THEIR BEARING ON THE PATHOGENESIS OF MALFORMATIONS.

Authors:  M A FERGUSON-SMITH
Journal:  J Med Genet       Date:  1965-06       Impact factor: 6.318

4.  Sequential gonadoblastoma and choriocarcinoma.

Authors:  H S Gallager; R P Lewis
Journal:  Obstet Gynecol       Date:  1973-01       Impact factor: 7.661

Review 5.  Gonadoblastoma. A review of 74 cases.

Authors:  R E Scully
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

6.  Occurrence of tumors in dysgenetic gonads.

Authors:  J Teter; K Boczkowski
Journal:  Cancer       Date:  1967-08       Impact factor: 6.860

7.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

8.  Radioimmunoassay for human follicle-stimulating hormone.

Authors:  A R Midgley
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

9.  Demonstration of an FSH receptor in a functioning granulosa cell tumour. The effect of gonadotrophin treatment on its viability following transplantation to nude mice.

Authors:  M Davy; P A Torjesen; A Aakavaag
Journal:  Acta Endocrinol (Copenh)       Date:  1977-07

10.  Localization of prolactin binding in prostate and testis: The role of serum prolactin concentration on the testicular LH receptor.

Authors:  C Aragona; H G Bohnet; H G Friesen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.